Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET

Detecting tumor lesions

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmaceutics 2022-09, Vol.14 (9), p.1928
Hauptverfasser:	Matsumoto, Hiroki, Igarashi, Chika, Tachibana, Tomoko, Hihara, Fukiko, Shinada, Mitsuhiro, Waki, Atsuo, Yoshida, Sei, Naito, Kenichiro, Kurihara, Hiroaki, Ueno, Makoto, Ito, Kimiteru, Higashi, Tatsuya, Yoshii, Yukie
Format:	Artikel
Sprache:	eng
Schlagworte:	64Cu-NCAB001 Analysis Antibodies Care and treatment Chromatography Diagnosis Dosimetry extended single dose toxicity study Hematology ipPET Laboratories Mass spectrometry Pancreatectomy Pancreatic cancer Patient outcomes PET imaging Pharmacokinetics Potassium preclinical safety Scientific imaging Urinalysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!